Expert Commentary
Why FDA hearing on morcellation safety could drive innovation
Reaction from Cheryl Iglesia, MD, Advisory Panel Member, to FDA’s 2-Day Hearing
Ceana Nezhat, MD, and Erica Dun, MD, of the Atlanta Center for Minimally Invasive Surgery and Reproductive Medicine, Atlanta, Georgia, present this surgical case of a 41-year-old G0 with radiating lower abdominal pain and mennorhagia who desired removal of her symptomatic myomas. Preoperative transvaginal ultrasound revealed a 4-cm posterior pedunculated myoma and 5-cm fundal intramural myoma.
